Due to the very high amount of private mutations in the peripheral sample of patient 4 compared to all other samples and as the MSH6 mutation was classified as “putative driver mutation”, we wanted to further study its possible contribution to the pathogenesis and ITH of this tumor. This evidence concerns the gene MSH6 and neoplasm.